Rep. Greg Landsman Sells Off Shares of Pfizer Inc. (NYSE:PFE)

Representative Greg Landsman (D-Ohio) recently sold shares of Pfizer Inc. NYSE: PFE. In a filing disclosed on November 14th, the Representative disclosed that they had sold between $1,001 and $15,000 in Pfizer stock on October 15th. The trade occurred in the Representative's "ROCKEFELLER CAPITAL MANAGEMENT (2)" account.

Representative Greg Landsman also recently made the following trade(s):

• Sold $1,001 - $15,000 in shares of Cheniere Energy NYSE: LNG on 10/15/2024.
• Sold $15,001 - $50,000 in shares of Phillips 66 NYSE: PSX on 10/15/2024.
• Sold $15,001 - $50,000 in shares of Diamondback Energy NASDAQ: FANG on 10/15/2024.
• Sold $1,001 - $15,000 in shares of NextEra Energy NYSE: NEE on 10/15/2024.
• Sold $1,001 - $15,000 in shares of Linde NASDAQ: LIN on 10/15/2024.
• Sold $1,001 - $15,000 in shares of Regeneron Pharmaceuticals NASDAQ: REGN on 10/15/2024.
• Sold $1,001 - $15,000 in shares of CrowdStrike NASDAQ: CRWD on 10/15/2024.
• Sold $15,001 - $50,000 in shares of Exxon Mobil NYSE: XOM on 10/15/2024.
• Sold $15,001 - $50,000 in shares of Amazon.com NASDAQ: AMZN on 10/15/2024.
• Purchased $1,001 - $15,000 in shares of NextEra Energy NYSE: NEE on 9/10/2024.

Pfizer Stock Down 4.7 %

PFE stock traded down $1.22 during trading on Friday, reaching $24.80. The stock had a trading volume of 131,074,383 shares, compared to its average volume of 38,229,605. The firm has a fifty day moving average price of $28.64 and a 200 day moving average price of $28.64. The company has a current ratio of 1.00, a quick ratio of 0.73 and a debt-to-equity ratio of 0.63. The company has a market capitalization of $140.54 billion, a P/E ratio of 33.51, a PEG ratio of 0.85 and a beta of 0.67. Pfizer Inc. has a 1-year low of $24.48 and a 1-year high of $31.54.

Pfizer (NYSE:PFE - Get Free Report) last posted its quarterly earnings data on Tuesday, October 29th. The biopharmaceutical company reported $1.06 EPS for the quarter, beating analysts' consensus estimates of $0.64 by $0.42. The firm had revenue of $17.70 billion for the quarter, compared to the consensus estimate of $14.92 billion. Pfizer had a net margin of 7.07% and a return on equity of 16.28%. The firm's revenue was up 31.2% compared to the same quarter last year. During the same period in the prior year, the firm posted ($0.17) EPS. On average, equities analysts anticipate that Pfizer Inc. will post 2.96 earnings per share for the current year.

Pfizer Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, December 2nd. Investors of record on Friday, November 8th will be issued a dividend of $0.42 per share. This represents a $1.68 dividend on an annualized basis and a yield of 6.77%. The ex-dividend date is Friday, November 8th. Pfizer's payout ratio is 227.03%.

Insider Activity at Pfizer

In other news, Director Scott Gottlieb acquired 1,000 shares of the business's stock in a transaction that occurred on Wednesday, October 30th. The stock was acquired at an average cost of $28.24 per share, for a total transaction of $28,240.00. Following the completion of the acquisition, the director now owns 10,000 shares in the company, valued at approximately $282,400. The trade was a 11.11 % increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.06% of the stock is currently owned by insiders.

Institutional Trading of Pfizer

Several large investors have recently added to or reduced their stakes in PFE. Geode Capital Management LLC raised its position in Pfizer by 1.6% during the third quarter. Geode Capital Management LLC now owns 117,666,245 shares of the biopharmaceutical company's stock valued at $3,392,342,000 after buying an additional 1,855,419 shares during the period. Frisch Financial Group Inc. grew its stake in Pfizer by 3.9% during the 3rd quarter. Frisch Financial Group Inc. now owns 34,334 shares of the biopharmaceutical company's stock valued at $994,000 after acquiring an additional 1,287 shares in the last quarter. Brophy Wealth Management LLC acquired a new position in shares of Pfizer in the 3rd quarter valued at about $945,000. Executive Wealth Management LLC purchased a new stake in shares of Pfizer in the third quarter worth approximately $476,000. Finally, Nabity Jensen Investment Management Inc acquired a new stake in shares of Pfizer during the third quarter worth approximately $347,000. 68.36% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

PFE has been the topic of several analyst reports. Daiwa America raised Pfizer from a "moderate buy" rating to a "strong-buy" rating in a research report on Wednesday, August 7th. Citigroup started coverage on shares of Pfizer in a research report on Friday, October 25th. They issued a "neutral" rating and a $30.00 price objective on the stock. Evercore ISI upgraded shares of Pfizer to a "strong-buy" rating in a research report on Wednesday, October 30th. Sanford C. Bernstein assumed coverage on Pfizer in a report on Thursday, October 17th. They set a "market perform" rating and a $32.00 price target on the stock. Finally, Wells Fargo & Company raised their target price on Pfizer from $28.00 to $30.00 and gave the company an "equal weight" rating in a research report on Wednesday, July 31st. One analyst has rated the stock with a sell rating, eight have assigned a hold rating, five have assigned a buy rating and three have given a strong buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $32.92.

About Representative Landsman

Greg Landsman (Democratic Party) is a member of the U.S. House, representing Ohio's 1st Congressional District. He assumed office on January 3, 2023. His current term ends on January 3, 2025. Landsman is also a member of the Cincinnati City Council in Ohio. He assumed office on January 2, 2018. His current term ends on January 1, 2024. Landsman (Democratic Party) is running for re-election to the U.S. House to represent Ohio's 1st Congressional District. He declared candidacy for the 2024 election. Greg Landsman was born in Cincinnati, Ohio, and lives in Mt. Washington, Ohio. Landsman earned a B.A. in economics and political science from Ohio University and an M.A. in theological studies, religion, and public policy from Harvard University in 2004. His career experience includes working as the executive director of The Strive Partnership with the KnowledgeWorks Foundation and the director of the Ohio Governor's Office of Faith-Based and Community Initiatives.

Pfizer Company Profile

Pfizer Inc discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands.